BIT Capital’s Cymabay Therapeutics CBAY Stock Holding History

BIT Capital’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,206	Closed	-$194K	–	140
2023 Q4	$194K	Sell	8,206 -3,122	-28%	-$55.6K	0.02%	72
2023 Q3	$169K	Buy	+11,328	New	+$150K	0.02%	89

Other funds holding CBAY

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BIT Capital's CBAY Position: Q1 2024 in Review

BIT Capital sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 8,206 shares — an estimated $194K sold.

BIT Capital first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $194K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

BIT Capital reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
BIT Capital sold 8,206 Cymabay Therapeutics shares in Q1 2024, an estimated $194K.
BIT Capital first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
BIT Capital's Cymabay Therapeutics position peaked at $194K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on BIT Capital's 13F filing for Q1 2024, filed 12 Feb 2025.